Core Viewpoint - The stock of 加科思-B (01167) has increased by over 3%, reflecting positive market sentiment following significant insider buying and a share repurchase plan [1] Group 1: Insider Buying - The company's chairman and CEO, Dr. Wang Yinxiang, along with concerted parties, invested nearly 100 million HKD to purchase over 11.05 million shares [1] - This substantial insider buying indicates strong confidence in the company's fundamentals and long-term growth prospects [1] Group 2: Share Repurchase Plan - The previously announced share repurchase plan of 100 million HKD has been initiated, with approximately 26.7 million HKD executed so far [1] - The company plans to continue this repurchase program over the next year, further demonstrating commitment to enhancing shareholder value [1] Group 3: Business Performance - The company reports that its current business operations are performing well, with encouraging progress in the development of its core product pipeline, including the Pan-KRAS inhibitor [1] - Management's actions, including the insider buying and share repurchase, reflect a unified and clear confidence in the company's operational status and future growth [1]
港股异动 | 加科思-B(01167)涨超3% 董事长及一致行动人斥资近1亿港元增持股份